Steven Cohen View Ray, Inc. Transaction History

Point72 Asset Management, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.35 - $3.28 $4,084 - $38,280	-11,671 Reduced 80.25%	2,873 $1,000
Q1 2023 May 15, 2023	BUY	$3.28 - $4.81 $47,704 - $69,956	14,544 New	14,544 $50,000
Q2 2022 Aug 15, 2022	SELL	$2.42 - $4.05 $4.48 Million - $7.49 Million	-1,850,373 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.45 - $5.83 $2.99 Million - $5.06 Million	-868,006 Reduced 31.93%	1,850,373 $7.25 Million
Q4 2021 Feb 14, 2022	BUY	$4.89 - $7.59 $6.36 Million - $9.87 Million	1,299,811 Added 91.63%	2,718,379 $15 Million
Q3 2021 Nov 15, 2021	BUY	$5.18 - $7.41 $402,589 - $575,905	77,720 Added 5.8%	1,418,568 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$3.94 - $6.75 $1.52 Million - $2.6 Million	384,987 Added 40.28%	1,340,848 $8.85 Million
Q1 2021 May 17, 2021	BUY	$4.03 - $7.25 $3.85 Million - $6.93 Million	955,861 New	955,861 $4.16 Million
Q2 2019 Aug 14, 2019	SELL	$6.7 - $9.13 $654,590 - $892,001	-97,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.7 - $8.73 $556,890 - $852,921	97,700 New	97,700 $722,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.